[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BioCentury BioCentury
BioCentury posts on X about kong, hong kong, finance, $192m the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXXX +667%
- X Months XXXXXXX +84%
- X Year XXXXXXX +18%
Mentions: X #
- X Week XX -XX%
- X Month XX -XXXX%
- X Months XXX -XXXX%
- X Year XXX -X%
Followers: XXXXXX #
- X Week XXXXXX +0.24%
- X Month XXXXXX +0.93%
- X Months XXXXXX +1.90%
- X Year XXXXXX +2.80%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance travel destinations stocks
Social topic influence kong, hong kong, finance, $192m, asia, $1530hk, investment, $7475m, $15b, ipos
Top accounts mentioned or mentioned by @usfda @usfdas @steveusdin1 @jeff_cranmer @fishburnsimone @stephenphansen @oppenheimer @novartis @vertexpharmas @biobonanos @marketwirenews @jnjnews @biauk @daniellegolovin @sareptas @lillypad @cmsgov @novonordisk @pfizer @abbvies
Top assets mentioned Novartis AG (NVS)
Top Social Posts #
Top posts by engagements in the last XX hours
"Third patient dies from acute liver failure caused by a Sarepta gene therapy"
@BioCentury on X 2025-07-18 00:00:08 UTC 16.3K followers, 93.2K engagements
"Capital flows continue in Asia. Ascentage Pharma raises $192M in Hong Kong placement while Korea-based Illimis raises $XX million in a series B round: BioCentury's latest Finance Report" @BioCentury on X 2025-07-18 21:30:12 UTC 16.3K followers, XXX engagements
"In BioCentury's Public Equity Report: Amid a difficult stretch for IPOs Nanjing Leads Biolabs has priced a HK$1.5B offering in Hong Kong; plus Abivax's $747.5M follow-on Pfizer's investment in 3SBio and more" @BioCentury on X 2025-07-25 20:30:12 UTC 16.3K followers, XXX engagements
"BioCentury's latest biopharma Management Moves: Steve Bates longtime head of BIA named executive chair of U.K.s Office of Life Sciences. Plus: Novartis names Mazuk chief patient experience officer and updates from Seres and ABPI" @BioCentury on X 2025-07-22 22:30:04 UTC 16.3K followers, XXX engagements
"In BioCentury's Venture Report: Australia's Brandon Capital closed its sixth fund at A$439M far outsizing the firm's previous vehicles; plus Dispatch's $216M launch and more" @BioCentury on X 2025-07-24 23:00:07 UTC 16.3K followers, XXX engagements
"Seed/Series A money up in 1H25 but mostly a few companies raising monster rounds: a BioCentury Data Byte" @BioCentury on X 2025-07-18 19:30:10 UTC 16.3K followers, XXX engagements